CBNS researchers have a range of links with organisations in the health and medical sector. These relationships are typically led by one of our Chief Investigators and link with hospitals and medical research institutes. The collaborations provide an opportunity for bio-nano research to be undertaken in collaboration with medical researchers and practitioners, informed by end-user needs.
Current collaborations are detailed below. For more information please contact the CBNS researcher listed.
We also have significant industry and commercial engagements.
The CBNS seeks new collaborations. If you have ideas for collaborative research in the health and medical sector please contact any of our researchers, the CBNS Director or Centre Manager.
Feel free to read our IP and commercialisation policy. Further information can be obtained from the CBNS Centre Manager.
| Collaborating Company | Main Contact | Project |
|---|---|---|
| Aarhus University Denmark | Professor Stephen Kent | Clinical trials of approaches to cure HIV |
| Adult Cancer Centre | Professor Maria Kavallaris | Glioblastoma micro RNA as therapeutic targets |
| Alfred Hospital | Professor Stephen Kent Dr Angus Johnston |
Analysis of influenza immunity |
| Alfred Hospital | Professor Stephen Kent Professor Rob Parton Dr Angus Johnston |
Analyses of the interactions of nanoparticles with a wide range of primary cells within human blood |
| Australian eHealth Research Centre | Professor Andrew Whittaker | Glioma imaging and therapy |
| Baker IDI Heart & Diabetes Institute | Professor Frank Caruso | Multifunctional polymer capsules for specific targeting for diagnostic and therapeutic use |
| bioCSL | Professor Stephen Kent | Improved influenza vaccines |
| Boulos & Cooper Pharma | Professor Clive Prestidge | Preclinical development of the novel antibiotic Ramizol |
| Burnet Institute Melbourne | Professor Stephen Kent | Novel molecules to measure immune responses |
| Centre for Cancer Biology | Professor Nico Voelcker | Surface modifications to encourage endothelial progenitor capture and expansion |
| EPSRC Cyclops Network | Professor Kris Thurecht | “SPI-CLOPS” (Surface Polymer Imprinted Closed Loop Optical Patient Sensors) for Dose Detection and Prevention of Cancer Resistance |
| Fondazione IRCCS Istituto Nazionale dei Tumori | Professor Frank Caruso | Redox-active polymers and polymer multilayered capsules to target prostate cancer cells |
| Fudan University, Oxford University and WHO Influenza Centre | Professor Stephen Kent Dr Angus Johnston |
Novel assays to study influenza immunity |
| Gebze Technical University, Turkey | Professor Andrew Whittaker | Novel porphyrin-based MRI agents |
| GlaxoSmithKline and the Doherty Institute | Professor Stephen Kent | Novel drugs to inhibit HIV entering the latent phase |
| Holman Pharma Pty Ltd | Professor Clive Prestidge | Improving oral delivery of poorly permeable drugs |
| Hubei University | Professor Andrew Whittaker | Novel MRI and optical imaging agents |
| Hudson Institute of Medical Research | Professor Nico Voelcker | Nanoparticle based drug delivery vehicles for the treatment of glioblastomas |
| Imperial College London UK | Professor Stephen Kent | Clinical trials of new HIV vaccines |
| Max-Planck Institute for Polymer Research | Professor Andrew Whittaker | Novel hyperpolarized imaging agents |
| Merck | Professor Stephen Kent | Novel delivery mechanisms to reduce harmful inflammation in infectious diseases such as HIV |
| Minomic, InterK, Clarity Pharmaceuticals | Professor Kris Thurecht | ARC Industrial Transformational Training Centre – ARC Training Centre in Biomedical Imaging Technology |
| National AIDS Research Institute of India, International AIDS Vaccine Initiative and Alfred Health | Professor Stephen Kent | Developing improved measurements of HIV immunity across different population groups |
| National Centre for Nanoscience and Technology | Professor Andrew Whittaker | Vascular remodelling and drug delivery |
| National Tsing Hua University | Professor Andrew Whittaker | Novel nanocomposites for bone regeneration |
| Peter MacCallum Cancer Institute | Professor Frank Caruso | Cytometer by Time of Flight (CyTOF) for the analysis of nano-bio interactions at the single-cell level |
| Prince of Wales Hospital | Professor Maria Kavallaris | Targeting microtubule proteins for chemosensitisation of lung cancer cells |
| QIMR-Berghofer Medical Research Institute | Professor Kris Thurecht | Development and testing of targeted theranostics for melanoma |
| QIMR-Berghofer Medical Research Institute | Professor Kris Thurecht | Testing of novel antibodies as imaging agents for prostate cancer |
| QIMR-Berghofer Medical Research Institute | Professor Andrew Whittaker | Novel antibodies for brain cancer imaging and therapy |
| QIMR-Berghofer Medical Research Institute | Professor Rob Parton | The role of caveolar proteins, called cavins, in the response of cells to DNA damage |
| Queen Elizabeth Hospital Foundation | Professor Clive Prestidge | Novel formulations of nanoparticles in gels to facilitate controlled release and delivery to bacterial biofilms |
| Queensland University of Technology | Professor Andrew Whittaker | Novel dental composites |
| Reform Pharm Pty Ltd | Professor Clive Prestidge | Lipoceramic reformulation of cardiovascular drugs |
| Royal Adelaide Hospital | Professor Benjamin Thierry | Development of bioengineered in vitro tumour models for radiobiological studies |
| Royal Adelaide Hospital | Professor Nico Voelcker | Scaffolds and capsules for human islet implants, cell therapy manufacturing |
| Royal Adelaide Hospital and Stanford Cancer Centre (University of Stanford) – funded by the Garnett Passe and Rodney Williams Memorial Foundation | Professor Benjamin Thierry | Smart “Nano Tracer” for improved preoperative staging with MRI and PET |
| Shanghai University | Professor Andrew Whittaker | Novel thermoresponsive polymers for therapy |
| Singapore Bioimaging Consortium (A*STAR) | Professor Andrew Whittaker | Cell uptake and imaging |
| South Australian Health and Medical Research Institute | Professor Nico Voelcker | In vivo testing of siRNA delivery vehicles, access to bioimaging facilities |
| St Vincent’s Hospital Sydney | Associate Professor John McGhee |
3D MED-i – An exploration of immersive arts-led 3D visualisation and VR HMD in stroke rehabilitation |
| Sydney Children’s Hospital Network | Professor Maria Kavallaris | Testing of drug delivery vehicles for refractory paediatric cancer |
| Tianjin University | Professor Andrew Whittaker | Hydrogels for drug delivery |
| University of Washington Seattle | Professor Maria Kavallaris | Structural domains of beta-tubulin and their role in microtubule dynamics and transport |
| University of Illinois at Chicago | Professor Andrew Whittaker | MD simulations of polymer-bio interactions |
| Vanderbilt University, USA | Professor Stephen Kent | New antibodies to treat Influenza infection |
| Vaxxas | Dr Adam Wheatley Professor Stephen Kent |
Novel analyses on immune responses induced by nano patch |
| Wesley Hospital, Brisbane | Professor Kris Thurecht | Prostate Cancer Therapeutics |
| Women’s and Children’s Hospital | Professor Nico Voelcker | Scaffolds for regulatory T cell expansion |
